Equities research analysts forecast that Sapiens International Co. (NASDAQ:SPNS) will report sales of $78.19 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Sapiens International’s earnings, with estimates ranging from $77.68 million to $78.70 million. Sapiens International reported sales of $72.16 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 8.4%. The company is expected to issue its next quarterly earnings report before the market opens on Monday, August 5th.

According to Zacks, analysts expect that Sapiens International will report full year sales of $319.39 million for the current fiscal year, with estimates ranging from $318.47 million to $320.30 million. For the next fiscal year, analysts expect that the firm will post sales of $0.00. Zacks’ sales averages are a mean average based on a survey of research analysts that follow Sapiens International.

Sapiens International (NASDAQ:SPNS) last posted its quarterly earnings data on Monday, May 6th. The technology company reported $0.17 EPS for the quarter, topping the Zacks’ consensus estimate of $0.15 by $0.02. Sapiens International had a return on equity of 14.01% and a net margin of 5.45%. The company had revenue of $76.79 million for the quarter, compared to analyst estimates of $75.69 million. During the same period in the previous year, the firm earned $0.13 earnings per share. The firm’s quarterly revenue was up 8.2% on a year-over-year basis.

Several equities research analysts recently issued reports on the company. Zacks Investment Research downgraded Green Plains Partners from a “buy” rating to a “hold” rating in a report on Friday. BidaskClub cut American Superconductor from a “hold” rating to a “sell” rating in a research report on Monday, April 22nd. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Sapiens International currently has a consensus rating of “Hold” and a consensus price target of $15.50.

Shares of NASDAQ SPNS traded up $0.51 during midday trading on Tuesday, hitting $16.55. 30,309 shares of the stock traded hands. Sapiens International has a one year low of $10.11 and a one year high of $17.41. The company’s 50 day moving average is $16.39. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 0.42.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Navellier & Associates Inc raised its stake in Sapiens International by 107.9% during the second quarter. Navellier & Associates Inc now owns 92,483 shares of the technology company’s stock worth $1,537,000 after purchasing an additional 48,000 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its position in shares of Sapiens International by 12.8% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,030,241 shares of the technology company’s stock worth $15,742,000 after buying an additional 116,712 shares during the last quarter. Menora Mivtachim Holdings LTD. lifted its position in shares of Sapiens International by 5.1% in the 1st quarter. Menora Mivtachim Holdings LTD. now owns 163,999 shares of the technology company’s stock worth $2,506,000 after buying an additional 7,945 shares during the last quarter. ClariVest Asset Management LLC bought a new position in shares of Sapiens International in the 1st quarter worth about $752,000. Finally, Monarch Partners Asset Management LLC lifted its position in shares of Sapiens International by 49.2% in the 1st quarter. Monarch Partners Asset Management LLC now owns 35,856 shares of the technology company’s stock worth $548,000 after buying an additional 11,825 shares during the last quarter.

About Sapiens International

Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers software platform and solutions for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation, including Sapiens CoreSuite and Sapiens IDITSuite; and life, pension, and annuities, such as Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster.

Recommended Story: Resistance Level

Get a free copy of the Zacks research report on Sapiens International (SPNS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.